Skip to content
★ Sign in to follow
장

장순호

Board Director
Director
Total declarations
2
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (1 ops.)
—

Latest filing published 16 Apr 2026 for 화일약품.

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

장순호: trading record in brief

장순호 (board member) discloses dealings in 화일약품 to DART (FSS). We count 2 filings; the first trade dates from 13 January 2023 and the latest from 9 April 2026.

Both buying and selling appear: 1 purchase, against 1 sale. The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show no purchases and 1 sale.

Most recently, on 16 April 2026, the filings show an open-market sale in 화일약품. The last insider purchase was made public on 19 January 2023, 1,389 days ago. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Companies and markets linked to 장순호

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    이사Executives(filed)화일약품
    0DART
    ShareKRXDART:20260416000348
  • ▲
    Executives화일약품
    0DART
    16,233 sharesShareKRXDART:20230119000276
    Canonical exit: 13 Apr 2023 (T+90)

2 of 2 declarations